Pierrel SpA engages in the development, manufacturing, and marketing of medical therapies for the pharmaceutical, bio-pharmaceutical, and life science industries. It operates through the following business segments: Contract Manufacturing, Pharma, and Holding. The Contract Manufacturing division deals with the production of specialized pharmaceuticals. The Pharma division develops, registers, and licenses new drugs and medical devices. The Holding segment provides administrative and management services for the parent company and its subsidiaries. The company was founded on June 30, 2005 and is headquartered in Capua, Italy.